The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
Portfolio Pulse from
The Schall Law Firm has announced a class action lawsuit against Applied Therapeutics, Inc. for alleged securities fraud. The lawsuit claims violations of the Securities Exchange Act of 1934. Shareholders who purchased securities between January 3, 2024, and December 2, 2024, are invited to join the case.
February 08, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Applied Therapeutics, Inc. is facing a class action lawsuit for alleged securities fraud, which could negatively impact its stock price in the short term.
The announcement of a class action lawsuit for securities fraud is likely to create negative sentiment around Applied Therapeutics, Inc., potentially leading to a decline in its stock price. Legal challenges can affect investor confidence and result in increased volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100